Related Experiment Video
Updated: Mar 30, 2026

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
Hyperglycemia is a risk factor for high-grade envenomations after European viper bites (Vipera spp.) in children
I Claudet1, E Grouteau1, L Cordier2
1a Pediatric Emergency Department , Children Hospital , Toulouse , France ;
Insights
Initial hyperglycemia is a significant risk factor for severe viper bites in children. This finding helps predict envenomation severity and guide treatment decisions in pediatric cases.
Area of Science:
- Pediatric Emergency Medicine
- Toxicology
- Herpetology
Background:
- Hyperglycemia is noted in severe scorpion stings.
- The study investigated hyperglycemia in pediatric viper bites.
Purpose of the Study:
- To characterize clinical, biological, and therapeutic aspects of European viper bites in 83 children.
- To confirm hyperglycemia as a risk factor for high-grade envenomation.
Main Methods:
- Retrospective study (2001-2014) at a pediatric tertiary hospital.
- Data collected: demographics, accident details, snake ID, bite location, envenomation severity, lab results, treatment, and outcomes.
- Analysis of factors associated with high-grade envenomation.
Main Results:
- 83 children (mean age 7.4 years) were included; 17% had high-grade envenomation.
- Risk factors for high-grade envenomation included upper extremity bites, afternoon bites, severe pain, and high initial plasma glucose.
- Children with high-grade envenomation received specific immunotherapy (Viperfav™).
Conclusions:
- A link between initial hyperglycemia and the risk of severe viper envenomation in children is confirmed.
- Hyperglycemia is identified as a predictive factor for envenomation severity.
- Findings support incorporating glucose monitoring in pediatric viper bite management.
Context:
Hyperglycemia has been described in severe scorpion envenomation, we wanted to analyze if it was applicable to viper bites in children.
Aim:
To describe clinical, biological, and therapeutic characteristics of 83 children bitten by European viper (Vipera spp.) and to confirm that hyperglycemia is a risk factor for high-grade envenomation.
Material And Methods:
A retrospective study was conducted between 2001 and 2014 in the pediatric emergency department of a tertiary level children's hospital. Collected data were: age and sex of children; day and time of admission; day, time and circumstances of the accident; snake identification; bite location; envenomation severity; presence of fang marks; prehospital care; laboratory abnormalities, use of specific immunotherapy, associated treatments; length of stay; hospital course.
Results:
Eighty-three children were included (62 boys, 21 girls). The mean age was 7.4 ± 3.9 years. Bites were most often located on the lower extremities (66%). The classification of envenomation was: 83% low grade (absent or minor envenomation) and 17% high grade (moderate to severe envenomation). All high-grade envenomations received specific immunotherapy (Viperfav(TM), (Aventis Pasteur, MSD, Lyon, France). Being bitten on an upper extremity (odds ratio [OR] 51.1 95% class interval [CI] [6.1-424], p < 0.0001), during the afternoon (OR 13.4 95% CI [1.7-107.9], p = 0.015), feeling violent pain (OR 4.2 95% CI [1.1-16.5], p = 0.023), and high initial plasma glucose level (6.5 ± 1.7 mmol/L versus 5.0 ± 0.9 mmol/L, p = 0.027) were associated with a significant risk of high-grade envenomation.
Conclusion:
We have confirmed a potential link between initial hyperglycemia and the risk of progression to high-grade envenomation as well as its association with other published predictive factors.
Related Concept Videos
Hypoglycemia and Glucagon
Drug Toxicity: Risk factors
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Acute Pancreatitis II: Clinical Manifestations and Management
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Drug Toxicity: Allergic Reactions

